BR112016009488A8 - piperidil-etil-pirimidina substituída, seus usos, e composição farmacêutica. - Google Patents

piperidil-etil-pirimidina substituída, seus usos, e composição farmacêutica.

Info

Publication number
BR112016009488A8
BR112016009488A8 BR112016009488A BR112016009488A BR112016009488A8 BR 112016009488 A8 BR112016009488 A8 BR 112016009488A8 BR 112016009488 A BR112016009488 A BR 112016009488A BR 112016009488 A BR112016009488 A BR 112016009488A BR 112016009488 A8 BR112016009488 A8 BR 112016009488A8
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
substituted piperidyl
ethyl pyrimidine
piperidyl ethyl
pyrimidine
Prior art date
Application number
BR112016009488A
Other languages
English (en)
Other versions
BR112016009488B1 (pt
Inventor
Angeles Martinez-Grau Maria
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR112016009488A8 publication Critical patent/BR112016009488A8/pt
Publication of BR112016009488B1 publication Critical patent/BR112016009488B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

a presente invenção proporciona novos inibidoras da goat e os sais dos mesmos e composições farmacêuticas dos mesmos.
BR112016009488-3A 2013-11-14 2014-11-06 piperidil-etil-pirimidina substituída, seus usos, e composição farmacêutica BR112016009488B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13382460 2013-11-14
EP13382460.7 2013-11-14
PCT/US2014/064202 WO2015073281A1 (en) 2013-11-14 2014-11-06 Substituted piperidyl-ethyl-pyrimidine as ghrelin o-acyl transferase inhibitor

Publications (2)

Publication Number Publication Date
BR112016009488A8 true BR112016009488A8 (pt) 2018-01-30
BR112016009488B1 BR112016009488B1 (pt) 2021-01-19

Family

ID=49622771

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016009488-3A BR112016009488B1 (pt) 2013-11-14 2014-11-06 piperidil-etil-pirimidina substituída, seus usos, e composição farmacêutica

Country Status (40)

Country Link
US (1) US9035051B1 (pt)
EP (1) EP3068775B1 (pt)
JP (1) JP6159484B2 (pt)
KR (1) KR101739243B1 (pt)
CN (1) CN105636948B (pt)
AP (1) AP2016009189A0 (pt)
AR (1) AR098274A1 (pt)
AU (1) AU2014348967B2 (pt)
BR (1) BR112016009488B1 (pt)
CA (1) CA2926224C (pt)
CL (1) CL2016001023A1 (pt)
CR (1) CR20160184A (pt)
CY (1) CY1119489T1 (pt)
DK (1) DK3068775T3 (pt)
DO (1) DOP2016000070A (pt)
EA (1) EA028550B1 (pt)
ES (1) ES2647790T3 (pt)
HK (1) HK1222860A1 (pt)
HR (1) HRP20171648T1 (pt)
HU (1) HUE035590T2 (pt)
IL (1) IL244856A (pt)
JO (1) JO3302B1 (pt)
LT (1) LT3068775T (pt)
MA (1) MA39025B1 (pt)
ME (1) ME02841B (pt)
MX (1) MX2016006223A (pt)
NO (1) NO3068775T3 (pt)
NZ (1) NZ718373A (pt)
PE (1) PE20160609A1 (pt)
PH (1) PH12016500895A1 (pt)
PL (1) PL3068775T3 (pt)
PT (1) PT3068775T (pt)
RS (1) RS56533B1 (pt)
SG (1) SG11201602953YA (pt)
SI (1) SI3068775T1 (pt)
TN (1) TN2016000145A1 (pt)
TW (1) TWI538677B (pt)
UA (1) UA118034C2 (pt)
WO (1) WO2015073281A1 (pt)
ZA (1) ZA201602202B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR104673A1 (es) * 2015-04-15 2017-08-09 Lilly Co Eli Inhibidores de grelina o-aciltransferasa
AR104672A1 (es) * 2015-04-15 2017-08-09 Lilly Co Eli Inhibidores de grelina o-aciltransferasa
ES2874587T3 (es) * 2016-08-05 2021-11-05 Boehringer Ingelheim Int Derivados de oxadiazolopiridina para su uso como inhibidores de la grelina O-aciltransferasa (GOAT)
CN106478519B (zh) * 2016-10-10 2018-12-11 上海再启生物技术有限公司 一种2-甲基-4-氨基-6-氯嘧啶的制备方法
WO2019149658A1 (en) 2018-02-02 2019-08-08 Boehringer Ingelheim International Gmbh Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors
CA3087925A1 (en) * 2018-02-02 2019-08-08 Boehringer Ingelheim International Gmbh Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors
EP3746451B1 (en) * 2018-02-02 2023-07-12 Boehringer Ingelheim International GmbH Benzyl-, (pyridin-3-yl)methyl- or (pyridin-4-yl)methyl-substituted oxadiazolopyridine derivatives as ghrelin o-acyl transferase (goat) inhibitors
MX2020008116A (es) * 2018-02-02 2020-09-25 Boehringer Ingelheim Int Derivados de oxadiazolopiridina sustituidos con heterociclilo para usar como inhibidores de ghrelin o-aciltransferasa (goat).
CN108774221A (zh) * 2018-05-30 2018-11-09 王丽萍 一种goat抑制剂及其在肥胖和糖尿病中的应用
CN108516971A (zh) * 2018-05-30 2018-09-11 王丽萍 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用
CN108610337A (zh) * 2018-05-30 2018-10-02 王丽萍 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用
CN108558852A (zh) * 2018-05-30 2018-09-21 王丽萍 一种goat抑制剂及其在肥胖和糖尿病中的应用
CN108558849A (zh) * 2018-05-30 2018-09-21 王丽萍 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用
JP2023526351A (ja) 2020-05-22 2023-06-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アルキル７－アミノ－５－メチル－［１，２，５］オキサジアゾロ［３，４－ｂ］ピリジンカルボキシレートの製造方法
EP4153600A1 (en) 2020-05-22 2023-03-29 Boehringer Ingelheim International GmbH Continuous process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403686C (en) * 2000-03-23 2010-01-26 Merck & Co., Inc. Substituted piperidines as melanocortin receptor agonists
WO2005026211A2 (en) 2003-09-05 2005-03-24 Eli Lilly And Company Anti-ghrelin antibodies
US20070237775A1 (en) 2004-07-14 2007-10-11 Eli Lilly And Company Anti-Ghrelin Antibodies
US20090060920A1 (en) 2004-11-15 2009-03-05 Eli Lilly And Company Desacyl ghrelin antibodies and therapeutic uses thereof
JP4909284B2 (ja) 2005-01-26 2012-04-04 キストラー ホールディング アクチエンゲゼルシャフト 加速度又は圧力測定用の接地絶縁された圧電型センサ
WO2006091381A1 (en) 2005-02-23 2006-08-31 Eli Lilly And Company Humanized anti-ghrelin antibodies
WO2006124490A2 (en) * 2005-05-17 2006-11-23 Schering Corporation Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
CN101175759A (zh) * 2005-05-17 2008-05-07 先灵公司 作为治疗血脂异常的烟酸受体激动剂的杂环化合物
US20070213359A1 (en) * 2005-12-30 2007-09-13 Acadia Pharmaceuticals Inc. Bicyclic-nitrogen compounds as modulators of ghrelin receptor and uses thereof
EP2268143A4 (en) * 2008-03-20 2012-06-27 Forest Lab Holdings Ltd NEW PIPERIDINE DERIVATIVES AS INHIBITORS OF THE STEAROYL COA DESATURASE
AR091516A1 (es) * 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida

Also Published As

Publication number Publication date
HRP20171648T1 (hr) 2017-12-15
DOP2016000070A (es) 2016-05-30
JP2016537371A (ja) 2016-12-01
ES2647790T3 (es) 2017-12-26
EA028550B1 (ru) 2017-11-30
US9035051B1 (en) 2015-05-19
TWI538677B (zh) 2016-06-21
EA201690764A1 (ru) 2016-07-29
TN2016000145A1 (en) 2017-10-06
PT3068775T (pt) 2017-11-20
CA2926224A1 (en) 2015-05-21
US20150133474A1 (en) 2015-05-14
HK1222860A1 (zh) 2017-07-14
EP3068775B1 (en) 2017-09-06
JO3302B1 (ar) 2018-09-16
ZA201602202B (en) 2019-10-30
CL2016001023A1 (es) 2016-11-18
AU2014348967A1 (en) 2016-04-28
CY1119489T1 (el) 2018-03-07
DK3068775T3 (en) 2017-10-23
TW201529073A (zh) 2015-08-01
CN105636948A (zh) 2016-06-01
WO2015073281A1 (en) 2015-05-21
SI3068775T1 (sl) 2017-10-30
UA118034C2 (uk) 2018-11-12
RS56533B1 (sr) 2018-02-28
IL244856A0 (en) 2016-05-31
PL3068775T3 (pl) 2018-01-31
LT3068775T (lt) 2017-11-27
NO3068775T3 (pt) 2018-02-03
SG11201602953YA (en) 2016-05-30
MX2016006223A (es) 2016-08-08
KR101739243B1 (ko) 2017-05-23
AU2014348967B2 (en) 2017-05-04
AP2016009189A0 (en) 2016-05-31
EP3068775A1 (en) 2016-09-21
KR20160068926A (ko) 2016-06-15
CN105636948B (zh) 2017-10-24
PH12016500895B1 (en) 2016-06-20
CR20160184A (es) 2016-06-17
PH12016500895A1 (en) 2016-06-20
CA2926224C (en) 2017-05-02
HUE035590T2 (en) 2018-05-28
PE20160609A1 (es) 2016-07-03
AR098274A1 (es) 2016-05-18
NZ718373A (en) 2017-12-22
MA39025A1 (fr) 2017-05-31
IL244856A (en) 2017-07-31
MA39025B1 (fr) 2018-05-31
ME02841B (me) 2018-01-20
BR112016009488B1 (pt) 2021-01-19
JP6159484B2 (ja) 2017-07-05

Similar Documents

Publication Publication Date Title
BR112016009488A8 (pt) piperidil-etil-pirimidina substituída, seus usos, e composição farmacêutica.
BR112016008632A8 (pt) compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica
BR112018005497A2 (pt) compostos heterocíclicos e usos dos mesmos
BR102015032361A8 (pt) Compostos de quinazolina, usos dos mesmos, composição farmacêutica, kit e artigo de manufatura
CY1121928T1 (el) Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης
BR112017013491A2 (pt) compostos de pirimidina fundida para o tratamento de hiv
BR112016015365A8 (pt) composto, composição farmacêutica e uso de um composto
BR112016006319A2 (pt) inibidores de irak e usos dos mesmos
BR112015022191A8 (pt) compostos heteroarila e usos dos mesmos
BR112017006305A2 (pt) compostos heteroarila como inibidores de btk e usos dos mesmos
BR112013000599A2 (pt) deuterado n-etil-n-fenil-1,2-di-hidro-4-hidroxi-5-cloro-1-metil-2-oxoquinolino-3-carboxamida, os seus sais e suas utilizações
BR112016026291A2 (pt) Derivados do ácido borônico e usos terapêuticos dos mesmos
BR112013000607A2 (pt) 5-cloro-4-hidroxi-1-metil-2-oxo-n-fenil-1,2-di-hidroquinolina-3-carboxamida, os sais e suas utilizações
BR112017013440A2 (pt) compostos de isoquinolina para o tratamento de hiv
BR112017005266A2 (pt) inibidores de mk2 e uso dos mesmos
BR112015032539A2 (pt) compostos ureia tricíclicos fundidos como inibidores de raf cinase e/ou dímero de raf cinase
BR112014033080A2 (pt) inibidores do vírus da hepatite c
BR112014017021A8 (pt) inibidores de irak e usos dos mesmos
BR112015028171A8 (pt) Inibidores de acc e seu uso
BR112014030655A8 (pt) Compostos inibidores de pirimidinil tirosina quinase, e composição farmacêutica que os compreende
BR112017028549A2 (pt) derivados de pirimidina como inibidores de btk e usos dos mesmos
EA202091397A1 (ru) Бензохинолоновые ингибиторы vmat2
BR112017018342A2 (pt) inibidores de grelina o-acil transferase
BR112017017835A2 (pt) inibidores de grelina o-acil transferase
BR112017002852A2 (pt) compostos de azetidiniloxifenilpirrolidina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/11/2014, OBSERVADAS AS CONDICOES LEGAIS.